Resolvin D2
中文名称 | Resolvin D2 |
---|---|
中文同义词 | |
英文名称 | Resolvin D2 |
英文同义词 | IKFAUGXNBOBQDM-XFMPMKITSA-N;RvD2;4,8,10,12,14,19-Docosahexaenoic acid, 7,16,17-trihydroxy-, (4Z,7S,8E,10Z,12E,14E,16R,17S,19Z)- |
CAS号 | 810668-37-2 |
分子式 | C22H32O5 |
分子量 | 376.49 |
EINECS号 | |
相关类别 | |
Mol文件 | 810668-37-2.mol |
结构式 |
Resolvin D2 性质
沸点 | 609.2±55.0 °C(Predicted) |
---|---|
密度 | 1.101±0.06 g/cm3(Predicted) |
储存条件 | Store at -80°C,protect from light |
溶解度 | DMF:50mg/mL;乙醇:50mg/mL; PBS(pH 7.2):0.05 mg/mL |
酸度系数(pKa) | 4.58±0.10(Predicted) |
形态 | 液体 |
颜色 | 无色至浅黄 |
TRP Channel
Resolvin D2 induces active resolution of inflammation with pulp-like tissue regeneration after root canal infection and thus maybe suitable for treating periapical lesions.
Resolvin D2 decreases leukocyte:endothelial interactions in vivo by endothelial-dependent nitric oxide production, and direct modulation of leukocyte adhesion receptor expression.
Peripheral administration of Resolvin D2 (10 ng; Intraplantar administration) potently inhibits inflammatory pain.
Animal Model: | Adult CD1 mice (male, 8–10 weeks) |
Dosage: | 10 ng |
Administration: | Intraplantar administration |
Result: | Inhibited inflammatory pain. |